XML 20 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Total
Balance at Dec. 31, 2021 $ 128 $ 167,032 $ (38) $ 12,099 $ 179,221
Balance (in shares) at Dec. 31, 2021 12,804        
Increase (Decrease) in Stockholders' Equity          
Shares of common stock issued in connection with employee stock purchase plan $ 1 3,035     3,036
Shares of common stock issued in connection with employee stock purchase plan (in shares) 115        
Shares of common stock issued in connection with incentive stock plan   274     $ 274
Shares of common stock issued in connection with incentive stock plan (in shares) 34       33,000
Shares used to pay taxes on stock grants   (992)     $ (992)
Shares used to pay taxes on stock grants (in shares) (34)        
Issuance of restricted stock award and units $ 4 (4)      
Issuance of restricted stock award and units (in shares) 377        
Stock-based compensation expense   8,373     8,373
Net income (loss)       (8,448) (8,448)
Net unrealized gain (loss) on derivative contracts     38   38
Balance at Dec. 30, 2022 $ 133 177,718 0 3,651 181,502
Balance (in shares) at Dec. 30, 2022 13,296        
Increase (Decrease) in Stockholders' Equity          
Shares of common stock issued in connection with employee stock purchase plan $ 2 2,779     2,781
Shares of common stock issued in connection with employee stock purchase plan (in shares) 182        
Shares of common stock issued in connection with incentive stock plan   182     $ 182
Shares of common stock issued in connection with incentive stock plan (in shares) 19       19,000
Shares used to pay taxes on stock grants   (205)     $ (205)
Shares used to pay taxes on stock grants (in shares) (11)        
Issuance of restricted stock award and units $ 2 (2)      
Issuance of restricted stock award and units (in shares) 196        
Stock-based compensation expense   5,323     5,323
Net income (loss)       10,926 10,926
Net unrealized gain (loss) on derivative contracts     (664)   (664)
Balance at Dec. 29, 2023 $ 137 185,795 (664) 14,577 $ 199,845
Balance (in shares) at Dec. 29, 2023 13,682       13,682,000
Increase (Decrease) in Stockholders' Equity          
Shares of common stock issued in connection with employee stock purchase plan $ 2 2,836     $ 2,838
Shares of common stock issued in connection with employee stock purchase plan (in shares) 164        
Shares of common stock issued in connection with incentive stock plan $ 2 2,757     $ 2,759
Shares of common stock issued in connection with incentive stock plan (in shares) 222       221,000
Shares used to pay taxes on stock grants $ (1) (1,406)     $ (1,407)
Shares used to pay taxes on stock grants (in shares) (48)        
Issuance of restricted stock award and units $ 2 (2)      
Issuance of restricted stock award and units (in shares) 149        
Stock-based compensation expense   7,388     7,388
Net income (loss)       22,570 22,570
Net unrealized gain (loss) on derivative contracts     350   350
Balance at Dec. 27, 2024 $ 142 $ 197,368 $ (314) $ 37,147 $ 234,343
Balance (in shares) at Dec. 27, 2024 14,169       14,169,000